Cerity Partners
HQL

Cerity Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Cerity Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,608
Closed -$213K – 2304
2024
Q1 		$213K Hold
15,608
– – ﹤0.01% 2079
2023
Q4 		$210K Buy
+15,608
New +$192K ﹤0.01% 1697
2023
Q3 		– Sell
-18,408
Closed -$249K – 1532
2023
Q2 		$249K Buy
+18,408
New +$254K ﹤0.01% 1449
2018
Q2 		– Sell
-10,000
Closed -$192K – 557
2018
Q1 		$192K Hold
10,000
– – 0.01% 504
2017
Q4 		$196K Hold
10,000
– – 0.01% 538
2017
Q3 		$215K Hold
10,000
– – 0.02% 525
2017
Q2 		$208K Hold
10,000
– – 0.02% 331
2017
Q1 		$194K Buy
+10,000
New +$185K 0.02% 417

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return

Cerity Partners's HQL Position: Q2 2024 in Review

Cerity Partners sold out of abrdn Life Sciences Investors (HQL) in Q2 2024, closing a stake of 15,608 shares — an estimated $213K sold.

Cerity Partners first reported a position in HQL in Q1 2017 and held it in 8 quarters. The position peaked at $249K in Q2 2023. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2024.

  • Cerity Partners reported no remaining abrdn Life Sciences Investors position as of Q2 2024 after selling out during the quarter.
  • Cerity Partners sold 15,608 abrdn Life Sciences Investors shares in Q2 2024, an estimated $213K.
  • Cerity Partners first reported a position in abrdn Life Sciences Investors in Q1 2017 and held it in 8 quarters.
  • Cerity Partners's abrdn Life Sciences Investors position peaked at $249K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2024.

Based on Cerity Partners's 13F filing for Q2 2024, filed 13 Aug 2024.